STOCK TITAN
  1. Home
  2. MGEN

MGEN (MGEN) Stock Price, News & Analysis

MGEN

Company Description

This page collects what Stock Titan holds for MGEN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

Latest News

View All
-0.09%

miRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansion of Leadership Team

management
+6.88%

miRagen Enters into License Agreement with Xencor for use of Xtend™ Antibody Technology for Investigational Antibodies to Treat Thyroid Eye Disease

0.00%

miRagen Reports Third Quarter 2020 Financial Results and Provides Corporate Updates

earnings
+142.35%

miRagen Therapeutics, Inc. Announces Acquisition of Viridian Therapeutics, Inc.

acquisition
-23.49%

miRagen Announces Internal Review of Preliminary Topline Data for the Phase 2 SOLAR Clinical Trial of Cobomarsen in Patients with Cutaneous T-Cell Lymphoma (CTCL)

clinical trial
-12.77%

miRagen Announces Leadership Transition and Review of Strategic Alternatives 

management

MGEN has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 6 with negative movement. Key topics include management, earnings, acquisition, clinical trial, fda approval. View all MGEN news →

SEC Filings

View All

No SEC filings available for MGEN.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months